87 results
Page 4 of 5
DRS
f5e4h xw5p8me1
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
i93mbht221mwm xq
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
d6f04mmbkkc8cnvt
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
rxyk5lh ybe2b7ut
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
o4jkulb
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
6-K
EX-99.1
rlzmhbj 4t92w
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
jkynnt 8vnbo
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
2mlgdr a7fiu
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.11.9
0qc2 ulymi7nl8
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.11.1
4jbzj2405p4
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
ea6rk0846 yxr3i
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.6
48h5qsq19 w7y
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.11.7
shchy
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.7
1bzoxq3
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
xfobm
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.1
j1jl0a fv
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-3.1
obteva0g mbjjgd4tuqs
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
ogsj pnan1mfz7u
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
mw3wf7 s4rt1gmgujl
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
03fhusk
29 May 20
Draft registration statement (amended)
12:00am